CAHIC(SH:600195)2020-10-30 16:00Financial Performance - Operating income for the first nine months was CNY 3,629,503,537.73, representing a year-on-year growth of 22.83%[17] - Net profit attributable to shareholders was CNY 486,088,018.07, up 78.82% from the same period last year[17] - The net profit after deducting non-recurring gains and losses was CNY 377,153,422.70, an increase of 41.10% year-on-year[17] - Basic earnings per share for the period was CNY 0.4799, reflecting a growth of 78.47% compared to the previous year[19] - Total operating revenue for Q3 2020 reached ¥1,359,358,371.05, an increase of 21.4% compared to ¥1,119,431,138.48 in Q3 2019[56] - Net profit for Q3 2020 reached ¥97.69 million, compared to ¥89.99 million in Q3 2019, reflecting an increase of 8.5%[63] - The company reported a total comprehensive income of approximately ¥136.50 million for Q3 2020, compared to ¥505.57 million in Q3 2019[60] Assets and Liabilities - Total assets at the end of the reporting period reached CNY 6,441,832,265.98, an increase of 13.20% compared to the end of the previous year[17] - The company's total equity as of September 30, 2020, was CNY 5,102,553,710.65, compared to CNY 4,639,189,557.82 at the end of 2019, representing a growth of about 10%[46] - The company's total liabilities amounted to CNY 1,339,278,555.33, up from CNY 1,051,250,206.88, reflecting an increase of approximately 27.4%[46] - Total current liabilities increased to CNY 1,195,002,015.54 from CNY 960,251,372.99, which is an increase of approximately 24.5%[46] - The total assets increased to ¥5,008,964,538.28 in Q3 2020, compared to ¥4,489,718,621.40 in Q3 2019, marking a growth of 11.6%[52] - The total liabilities rose to ¥743,949,602.63 in Q3 2020, up from ¥583,230,515.57 in Q3 2019, reflecting a 27.6% increase[52] Cash Flow - Cash flow from operating activities for the first nine months was CNY 207,859,464.08, a significant recovery from a negative cash flow of CNY -300,658,372.63 in the same period last year[17] - Cash inflow from operating activities for the first three quarters of 2020 was approximately ¥3.13 billion, up from ¥2.47 billion in the same period of 2019, representing an increase of about 26.9%[64] - Net cash flow from operating activities for Q3 2020 was negative at approximately -¥26.16 million, an improvement from -¥312.46 million in Q3 2019[71] - Cash inflow from investment activities for Q3 2020 was approximately ¥948.73 million, down from ¥2.20 billion in Q3 2019, indicating a decrease of about 57.0%[68] - The ending cash and cash equivalents balance for Q3 2020 was approximately ¥709.35 million, compared to ¥382.98 million at the end of Q3 2019, showing an increase of about 85.0%[68] Shareholder Information - The total number of shareholders at the end of the reporting period was 40,074[21] - The largest shareholder, China Animal Husbandry Group Co., Ltd., held 49.63% of the shares[21] Investments and Income - Investment income surged by 118.94% to RMB 321.91 million, mainly from the reduction of shares in Jindaiwei[28] - The company received cash from investment activities amounting to RMB 182.73 million, a 1,690.18% increase due to the sale of Jindaiwei shares[30] - The company reported a significant increase in other receivables, which reached CNY 75,104,671.69, compared to CNY 43,149,053.65 in the previous year, marking an increase of about 74.1%[40] Operational Metrics - The weighted average return on equity increased by 4.54 percentage points to 11.17%[17] - Research and development expenses for Q3 2020 amounted to ¥39,473,703.36, slightly down from ¥42,283,613.87 in Q3 2019[56] - The company’s investment income for Q3 2020 was ¥70.59 million, compared to ¥43.61 million in Q3 2019, showing a significant growth in investment performance[61] Other Financial Metrics - Tax payable rose by 154.27% to RMB 64.25 million, driven by increased profits[28] - The company reported a government subsidy of CNY 6,303,797.97 during the period, which is closely related to its normal business operations[19] - Estimated compensation for the brucellosis antibody positive incident is RMB 35 million, which has been accrued[33] - The company is actively cooperating with local government departments to manage the aftermath of the brucellosis incident[32]